Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Namaste Technologies Inc. (OTCMKTS: NXTTF) Soars on $51.7mm Financing
Namaste Technologies Inc. (OTCMKTS: NXTTF) is back on track after closing the bought deal financing including full exercise of over-allotment option for gross proceeds of $51,750,000. This is huge news for Namaste.
A total of 17,250,000 units of the Company were sold at a price of $3.00 per Unit, The Offering was completed by a syndicate of underwriters led by Eight Capital and Canaccord Genuity Corp. as co-lead underwriters and joint bookrunners, and including Laurentian Bank Securities Inc.
Namaste Technologies Inc. (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) has an ambitious vision to become the Amazon of medical marijuana. Namaste is led by avid Youtuber Sean Dollinger a serial entrepreneur with a history of founding and successfully operating several start-up companies mainly focused on e-commerce. Sean started selling vaporizers online and the business soon took off. Currently the Company has a huge web presence and international internet distribution network that records traffic from over 180 countries and directly reaches 26 countries in nine different languages. The company offers virtually all high end brand vaporizers. Some of Namaste’s websites include namastevapes.ca, namastevaporizers.co.uk, namastevaporizers.ie, everyonedoesit.com, everyonedoesit.co.uk, everyonedoesit.ca,namasteMD.com and grizzlyoriginals.com.
arlier this year Cannmart received confirmation from Health Canada that it will be allowed to buy pre-packaged, labelled and tested cannabis products. This development was very significant for Cannmart in that it will eliminate the need for buying in bulk, testing and packaging which will significantly reduce overhead costs for Cannmart and thus increase gross profit margins. By allowing Cannmart to purchase pre-packaged medical cannabis products, the Company can remain focused on its areas of expertise in e-commerce and technology, and enable the Company to further expand on the products and services that can be provided through Cannmart.
Namaste vision for Cannmart is an online marketplace that provides a competitive landscape whereby the many hundreds of licensed producers and micro-cultivators can offer their high-quality products. Currently there are over over 100 Lps in Canada so whether Aphria is one of them or not does not seem to make much difference.
https://www.microcapdaily.com/namaste-technologies-inc-otcmkts-nxttf-soars-on-51-7mm-financing/122200/
LOL, You're FUNNY! (Shorta)
These two pot stocks were given the OK to ship cannabis to the U.S.
MedMen but not Aurora? Kinda BS.. Aurora IS and WILL be the GLOBAL Leader!
Despite 30 states having passed sweeping usage laws on medical cannabis in the U.S., the federal government continues to hold the drug as a Schedule I substance. This means it's entirely illegal, is prone to abuse, and has no recognized medical benefits. As such, interstate transport of cannabis and cross-border transport, including imports and exports, are strictly forbidden. That's why niche retailers like MedMen Enterprises have had to operate grow farms in each state they have retail operations, since out-of-state transport isn't a legal possibility in the United States.
But over the past five weeks, the federal government -- or should I say, the U.S. Drug Enforcement Administration (DEA) -- has softened its stance a bit and permitted two Canadian marijuana growers the ability to import cannabis or cannabinoids for medical research studies.
On Sept. 18, Tilray (NASDAQ: TLRY) announced that it had received approval from the U.S. government to import a cannabinoid formulation containing cannabidiol and tetrahydrocannabinol (the psychoactive component that gets you high) for a clinical trial focused on essential tremor at the University of California, San Diego. Tilray is predominantly focused on providing products to the medical community, so it's expected to be reliant on exports to foreign markets (perhaps even the U.S. on a regular basis) moving forward. Since the U.S. government has just one federally approved grow facility, supply of medical cannabis can constrain research. This move by the DEA to permit the import of cannabinoids could be the first step to removing some of the red tape surrounding medical research.
These two pot stocks were given the OK to ship cannabis to the U.S.
Despite 30 states having passed sweeping usage laws on medical cannabis in the U.S., the federal government continues to hold the drug as a Schedule I substance. This means it's entirely illegal, is prone to abuse, and has no recognized medical benefits. As such, interstate transport of cannabis and cross-border transport, including imports and exports, are strictly forbidden. That's why niche retailers like MedMen Enterprises have had to operate grow farms in each state they have retail operations, since out-of-state transport isn't a legal possibility in the United States.
But over the past five weeks, the federal government -- or should I say, the U.S. Drug Enforcement Administration (DEA) -- has softened its stance a bit and permitted two Canadian marijuana growers the ability to import cannabis or cannabinoids for medical research studies.
On Sept. 18, Tilray (NASDAQ: TLRY) announced that it had received approval from the U.S. government to import a cannabinoid formulation containing cannabidiol and tetrahydrocannabinol (the psychoactive component that gets you high) for a clinical trial focused on essential tremor at the University of California, San Diego. Tilray is predominantly focused on providing products to the medical community, so it's expected to be reliant on exports to foreign markets (perhaps even the U.S. on a regular basis) moving forward. Since the U.S. government has just one federally approved grow facility, supply of medical cannabis can constrain research. This move by the DEA to permit the import of cannabinoids could be the first step to removing some of the red tape surrounding medical research.
Agree! Same here, and she (CEO) seems to have a lot of enthusiasm around Marijuana and Opiod help etc.
8.42 Pre-Market!
The NYSE Welcomes One Of Ontario's Most Popular Cannabis Brands - Aurora Cannabis
THIS IS GOOD! LONGS KNOW
On October 23, Aurora Cannabis (ACBFF) begins trading as ACB on the New York Stock Exchange - becoming only the fourth Canadian cannabis company to receive a US listing (soon to be joined by a fifth, as I discussed last week).
Despite - or perhaps because of - legalization of recreational cannabis on October 17, it has been a rough week for cannabis shareholders. Despite losses of ~25% over the past five days, investors should keep a longer-term view: Aurora Cannabis is still up 55% in the past three months and is up 300% in the past year (from C$2.86/share to C$11.42/share).
Cannabis companies will continue to gain in the long term as popular support continues to rally behind cannabis legalization. A recent poll in the United States shows that support for legalizing cannabis is at an all-time high, with two-thirds of Americans supporting legalization. This support extends across party lines - with a majority of Republicans and Democrats alike supporting legal cannabis - and across age ranges and geography as well. And Americans are not alone: Liberalization of cannabis is a global trend and not limited to the United States and Canada. Aurora - and peers like Canopy Growth (CGC) - will benefit from this liberalization trend.
https://seekingalpha.com/article/4213508-nyse-welcomes-one-ontarios-popular-cannabis-brands-aurora-cannabis
Guys the whole MJ sector is in DEEP Red. Please have some patience? We were lucky to have a Green day yesterday as one of the Only MJ stocks to be Green?
We have been in the Green the past few days while everyone else has been struggling hard for 4 days straight RED. Looks like we are joining the party for a short period of time and will get to new higher levels in a month or less.
GLTA! ADVT - Stay Strong!
Nice Buy! Good Luck Bro! Also INND should be hot today?
HAHA. I dont need to do anything but watch the PPS go up. I don't know what you're talking about. Fidelity is all SET and DONE when I woke up. Fix your account issues and stop dragging other folks into your mess? Thanks!
PotNetwork Holdings Reports $18.1 Million in Sales Surpassing Entire Revenue Generated in 2017
Exceeding Last Year’s 9-Month Performance by 90%, Company Prepares for Exciting Final Quarter of 2018
Fort Lauderdale, FL -- October 23, 2018 -- InvestorsHub NewsWire -- PotNetwork Holdings, Inc. (OTC Pink: POTN) today announced sales of $18.1 Million for the first 9 months of the year, realizing an $8.6 Million increase in year over year sales. This follows the Company’s recent announcement of its record third quarter revenues of $6.1 Million.
Driven by the growth of its wholly-owned subsidiary, Diamond CBD, Inc., PotNetwork Holdings, Inc. has taken root as an industry leader in the growing market for premium hemp extracts. PotNetwork Holdings is expanding its research and development, multinational marketing and international distribution of a broad range of hemp-derived cannabinoids and other natural hemp derivatives.
PotNetwork Holdings also reported that sales of Diamond CBD Products are coming 60% from its wholesale distribution network and 40% from online sales including from www.diamondcbd.com.
“I am extremely pleased with our year-over-year growth,” said Kevin Hagen, president of Diamond CBD. “We provide customers with a high-quality product with lab reports attached to each product displayed online. It is part of our commitment to transparency in providing the highest quality CBD to our customers.”
PotNetwork Holdings expects to file its quarterly report for the 9 months ended September 30, 2018 on or before November 14, 2018. The quarterly report will contain a further breakdown of the Company’s revenue and earnings.
No Loans or Non-Arm’s Length Transactions. Neither the Corporation nor any of the subsidiaries is a party to any Debt Instrument or has any material loans or other indebtedness outstanding which has been made to any of its shareholders, officers, directors or employees, past or present, or any Person not dealing at arm’s length with the Corporationoranysubsidiary
Thanks ERPY!!
Advantis Corp. Developing Own Brand of Edibles, CBD Product Lines
NEWPORT BEACH, CA, Oct. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) revealed today that they have been developing its own brand of cannabis-infused edibles, Amster Edibles. Advantis also revealed that it is close to releasing a full line of self-branded CBD products.
“Last week we announced that we are receiving pallet sized orders for Amster-Can edible packaging,” CEO, Darren Cherry, explained. “Now I can reveal that we have been working on our own brand of edibles with our partner Natural Elements. Demand for edibles has always existed, but now we have the see-through cans and are completing a thorough product testing process; we will enter the marketplace with only the highest quality edibles, thanks to our expanding list of partners. Gummies will likely be the first, and they are deliciously effective.”
Cherry says that there are already orders for the gummy candies, and he anticipates being able to distribute the entire line of edibles and CBD products through its existing product pipeline. “Edibles and CBD products have presented a real opportunity for Amst,er-Can to capitalize on the greater packaging need. There is a much higher consumption rate with edibles; an eighth may last someone a week, whereas an edible, can be consumed in a day. We’ve gone from three thousand-unit orders to pallet size orders, just because of the growing demand for edibles -- that’s more than a tripling of orders.” Cherry mentioned that finalizing the Orange County location will enable the company to more rapidly expand its capacity, then said, “We have much in the works and have some exciting news we expect to announce next week.”
Cherry highlighted recent developments with Kimo, since announcing his contributions to the company last week. “We love Kimo, and Kimo really loves our products,” Cherry said. “He has opened my eyes in a lot of ways. Many current and retired professional athletes have found cannabis to be an effective replacement for doctor-prescribed opiates. A lifetime of injury and pain in every sport leads almost every athlete toward pain killers and anti-inflammatories; out of necessity to deal with an ailment that ultimately cannot be healed.” According to a USA today article written in April of this year, former athletes estimate that about 80% of NFL and NBA players use or have used marijuana; mostly for pain. “Kimo has an extensive network of friends and colleagues that span every sport, and he is opening the door to his network,” Cherry related. “I am proud to be able to help athletes find a healthier way to manger their pain. I will also be proud as additional athletes join the Advantis family to represent and attest to the value and quality of our product lineup.”
Advantis Corp. Partners with NFL Great, Kyle Turley, Expands Product Lineup Three-Fold
Sharing the news on here since no one else sharing? We all know this by now, but some may not
NEWPORT BEACH, CA, Oct. 22, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced that is has partnered with former NFL offensive lineman, Kyle Turley, to help market and distribute Amster-Can products. Turley, board member of the Gridiron Greats Assistance Fund, which provides medical and other assistance to retired football players, has been a vocal advocate for cannabis. Turley is also the founder of Neuro XPF, and member of Shango, a Las Vegas based company that holds medical and recreational distribution licenses in Oregon, Washington, and Nevada; they will also soon be fully licensed in California and Michigan.
Advantis has shown a pattern of developing synergistic partnerships, and clearly established this relationship in this same vein. Advantis CEO, Darren Cherry, says this partnership will quickly grow the Amster-Can product line, increase distribution channels, and visibility for the fast-growing company. “We can’t wait to can Mister Turley’s favorite strain, Saint Jack,” Cherry exclaimed. “In addition to canning for his businesses, we will be creating an arrangement to add additional strains to our Amster-Can branded products.” Advantis has previously only provided three strains that were grown by mutual benefit in cooperation with, Natural Elements. As business has expanded, Advantis’ needs have resulted in them seeking out additional partnerships to help fill the surging demand for Amster-Can products.
Last month, Advantis announced a product expansion with Master Win in Northern California; then they announced the edible expansion and branding; with this newest partnership, Advantis will be able to almost immediately expand its distribution channels. “We will now be able to take advantage of the distribution license that Shango has worked diligently to acquire. We round out our product lineup with the highest quality in the marketplace. Most importantly, we can now access additional markets in states that we’re not in yet,” Cherry explained. “We will have more than twelve strains available. Further, we have another partnership in development that will produce a similar synergistic relationship.” Shango is focused on securing licensing in every state where it’s possible too. They are able to navigate the legal and regulatory framework necessary to establish a legal cannabis operation in a given state. “I am very excited to have formed this relationship with Mister Turley. His reputation and advocacy for those in need is admirable and inspires me to do more.”
Kyle Turley played through pain throughout his twenty plus years of playing football. He was diagnosed with CTE, due to suffering over one hundred concussions, was addicted to pain killers, anti-inflammatories, and had suicidal thoughts until 2015, when he discovered the healing and pain-relieving effects of marijuana. “I went cold turkey in 2015,” Turley said. “I would not have my family, my kids, my house, everything I have right now, if not for cannabis.” Turley has spent the past several years advocating for cannabis studies, seeking rule changes regarding how the NFL views cannabis vs. doctor-prescribed opiates, and reaching out to help others that have suffered the pain, CTE, and opiate-addicted cycle that prevails in professional sports. His establishment of Neuro XPF was specifically to help those in professional sports with its patented CBD formula, that Turley has found most effective
John Boehner to host marijuana investing seminar
Just days after Canada formally legalized the recreational use of marijuana, former Republican Speaker of the House John Boehner, who notoriously chainsmoked throughout his time in Congress, is set to host an online event Tuesday targeted at prospective investors in cannabis.
The free program, which marks the official launch of the National Institute of Cannabis Investors, will begin at 1:00 p.m. ET.
Those tuning in will see the apparent culmination of what Boehner has called his long-running "evolution" on marijuana. Earlier this year, Boehner joined the advisory board of multi-state marijuana company Acreage Holdings, even though he said in 2011 that he was “unalterably opposed” to legalizing the drug. (He voted against legalizing medical marijuana in Washington, D.C. in 1999.)
As recently as 2015, Boehner came out against reclassifying marijuana under federal law, which currently considers marijuana as having no significant medical value, saying he was "concerned that legalization will result in increased abuse of all varieties of drugs, including alcohol."
But after seeing marijuana help a friend suffering from back pain, as well as tough sentences handed out for marijuana possession, Boehner says he changed his position.
“Over the last 10 or 15 years, the American people’s attitudes have changed dramatically,” Boehner said in an interview at the time. “I find myself in that same position.”
"The next generation of billion-dollar cannabis companies are ripe for the picking, you just have to make smart moves," Boehner said in a press release. "Don't go blindly investing in this sector because it's exciting and you don't want to miss the boat. Cannabis is here to stay, the industry is only getting bigger, and I am all in. With the information we are sharing on Tuesday, one can stake a claim for fractions of what they could be worth weeks or months from now."
A Pew Research Center poll from October shows that approximately 60 percent of Americans support legalizing marijuana, compared to a mere 31 percent in 2000. Far more Democrats than Republicans back the measure.
Nine states, plus the District of Columbia, permit the recreational use of marijuana. However, the drug remains illegal under federal law, and Attorney General Jeff Sessions has rolled back Obama-era protocols that discouraged criminal prosecution of medical marijuana dispensaries.
The move effectively unleashed federal prosecutors to consider bringing marijuana cases, while stopping short of ordering them to do so.
“U.S. attorneys need to make decisions in these cases as they do in other drugs cases,” a senior DOJ official told Fox News.
Joining Boehner at Tuesday's event will be Danny Brody, who spearheaded two major cannabis IPOs, and investment publisher Mike Ward.
https://www.foxnews.com/politics/john-boehner-to-host-marijuana-investing-seminar
Fidelity is on it :) ACB it is..
High Demand and Low Supply usually is a good thing? Remember when people were Selling because they were scared of the over-supply of MJ? LOL People act like they know everything.. but have no clue whats brewing behind the scenes.
HOLD Strong IMO.. Good times will come soon. This has all happened before and the MJ sector is getting manipulated badly.
Yes it is, please have a seat at any comfortable location
Whole MJ sector Manipulation -$80,000 today.. lol
Chart: Is marijuana already becoming a mainstream industry?
Broader consumer acceptance of marijuana across North America signals that the nascent industry may soon take a place among mainstream industries ranging from cosmetics to nonalcoholic beverages.
A majority of respondents to a recent survey by Chicago-based consulting firm A.T. Kearney noted that their perception of mainstream companies would not change if the businesses became associated with cannabis.
And in most consumer product categories, more than a quarter of respondents said their perception of those companies would actually improve.
“This really speaks to the mainstreaming of cannabis, which, for the overall industry, I think is a positive thing,” said Nancy Whiteman, CEO of Boulder, Colorado-based edibles maker Wana Brands.
Ironically, one “sin” industry would take more of a hit to its reputation than other mainstream sectors that diversify into cannabis.
Alcohol companies – one of the most active sectors with regard to cannabis investment – had the highest negative response among consumers, with 18% saying association with marijuana would worsen their perception of the firms.
But the case of alcohol was more the exception than the rule.
“The survey clearly demonstrates the viability of the market for cannabis across multiple consumer segments,” said Randy Burt, a partner in A.T. Kearney’s consumer and retail practice.
Looking ahead, the survey results could spell change among long-established cannabis companies that helped pioneer the legal industry.
The reason: Innovation and new product development will be critical to the survival of cannabis brands.
Wana Brands, for example, launched a disposable vape line last month, a departure from its signature edibles. The disposable vaporizers could address a unique need in popular tourist markets where visitors might want to sample a product but not stock up on accessories to drag back in their suitcase.
“Innovation is the key in any industry,” Whiteman said. “Innovate or die, and I think companies in this industry understand innovation at a different level. They know what’s effective and what’s not effective.”
Alternately, as mainstream brands look to enter the cannabis industry, leading companies may seek to acquire expertise that already exists in marijuana companies – either through the recruitment of employees or acquisition of a business.
Chart: Is marijuana already becoming a mainstream industry?
Broader consumer acceptance of marijuana across North America signals that the nascent industry may soon take a place among mainstream industries ranging from cosmetics to nonalcoholic beverages.
A majority of respondents to a recent survey by Chicago-based consulting firm A.T. Kearney noted that their perception of mainstream companies would not change if the businesses became associated with cannabis.
And in most consumer product categories, more than a quarter of respondents said their perception of those companies would actually improve.
“This really speaks to the mainstreaming of cannabis, which, for the overall industry, I think is a positive thing,” said Nancy Whiteman, CEO of Boulder, Colorado-based edibles maker Wana Brands.
Ironically, one “sin” industry would take more of a hit to its reputation than other mainstream sectors that diversify into cannabis.
Alcohol companies – one of the most active sectors with regard to cannabis investment – had the highest negative response among consumers, with 18% saying association with marijuana would worsen their perception of the firms.
But the case of alcohol was more the exception than the rule.
“The survey clearly demonstrates the viability of the market for cannabis across multiple consumer segments,” said Randy Burt, a partner in A.T. Kearney’s consumer and retail practice.
Looking ahead, the survey results could spell change among long-established cannabis companies that helped pioneer the legal industry.
The reason: Innovation and new product development will be critical to the survival of cannabis brands.
Wana Brands, for example, launched a disposable vape line last month, a departure from its signature edibles. The disposable vaporizers could address a unique need in popular tourist markets where visitors might want to sample a product but not stock up on accessories to drag back in their suitcase.
“Innovation is the key in any industry,” Whiteman said. “Innovate or die, and I think companies in this industry understand innovation at a different level. They know what’s effective and what’s not effective.”
Alternately, as mainstream brands look to enter the cannabis industry, leading companies may seek to acquire expertise that already exists in marijuana companies – either through the recruitment of employees or acquisition of a business.
I agree! NYSE TOMORROW?! Have to make the prices more attractive for the Big Investors I guess! Lets see what happens in a month?
HOLDING STRONG + FOR YEARS!
How Low can the SECTOR GO!?
RED SECTOR AGAIN LOL! DAMN! Was the shortage of MJ or close to running out of MJ after legalization the big SCARE?
ADVT Only Green MJ ticker the past week or one of the only few? Something huge is coming?!
Why are you wasting time with this clueless guy? Stick to the game plan, hold long & collect large bags, IMO. Volatile times but NXTTF will be a Giant soon! A little bumpy? Sure, but long term will be Great IMO
GLTA!
Sean Bought $3M worth of Namaste! Filing Date 1 Month ago exactly?
Remember:
Namaste is also working with IBM.. STOP GETTING FOOLED BY Distraction & Newbie Noise. HOLD for Profits, IMO.
Filing Date: Sep 19/18 Transaction Date: Sep 17/18 Dollinger, Sean Direct Ownership Common Shares 11 - Acquisition carried out privately 1,138,000 @ $2.96
I believe this guy is a programmer @ Namaste:
Sep 19/18 Transation Date: Sep 17/18 Sidhu, Kiranjit Singh Direct Ownership Common Shares 11 - Acquisition carried out privately 50,000 @ $2.9
GET EM! Good LUCK Erpy!
Lets GOO! I'm back in for the ride! Good luck SFT!
Until everyone here Owns a Business, Owns 20+ domains, on path to Nasdaq listing etc, please stop saying how fast they should be moving.
LOL - just because you can click your mouse 60 times a second, doesn't mean you know whats going on behind the scenes.
You need Patience. Learn that its not so easy to do a million tasks everyone wants you to do on i-Hub from their perspective (LOL) And still maintain and grow the business roots.
CHILL OUT FOLKS - you wont be millionaires in 1 week from Namaste. If you think you should make a million $ so easily, go ahead and create your own business, own, manage and develop all these websites and keep COMPLIANCE at the same time with all laws and not have people bash your company for growing.
I do own 3 business's and 6+ domains but im not on Nasdaq or anywhere CLOSE, so until you are.. PLEASE just sit back and watch the PPS without your "management skills on i-hub"
GLTA!